JOURNAL OF MOLECULAR DIAGNOSTICS
Scope & Guideline
Empowering healthcare with cutting-edge diagnostic insights.
Introduction
Aims and Scopes
- Molecular Diagnostic Techniques:
The journal extensively covers various molecular diagnostic techniques, including next-generation sequencing (NGS), polymerase chain reaction (PCR), and digital droplet PCR, highlighting their applications in clinical settings. - Cancer Genomics:
A significant focus on cancer genomics is evident, with research aimed at identifying genetic alterations in tumors, understanding tumor heterogeneity, and developing targeted therapies based on genomic profiles. - Clinical Utility of Molecular Testing:
Emphasis on the clinical utility of molecular testing for various conditions, including cancer, infectious diseases, and genetic disorders, to enhance patient management and treatment outcomes. - Consensus Guidelines and Recommendations:
The journal publishes consensus guidelines and recommendations from leading professional societies to standardize molecular diagnostic practices and ensure high-quality laboratory results. - Innovative Biomarker Discovery:
Research on discovering novel biomarkers for early disease detection and monitoring, particularly in oncology and hereditary conditions, is a core aspect of the journal's scope.
Trending and Emerging
- Liquid Biopsy Technologies:
Research on liquid biopsy technologies, particularly for cancer diagnostics and monitoring, is rapidly increasing, showcasing the potential for non-invasive testing methods to provide critical insights into tumor dynamics. - Integration of Artificial Intelligence:
The application of artificial intelligence and machine learning in analyzing genomic data and improving diagnostic accuracy is gaining traction, with numerous studies exploring innovative computational approaches. - Pharmacogenomics:
Increasing attention is being directed toward pharmacogenomics, with studies focusing on how genetic variations affect drug response, aiming to personalize treatment strategies for better outcomes. - Microbiome Research:
Emerging research on the human microbiome's role in health and disease, particularly its impact on cancer and infectious diseases, is becoming a key area of exploration within the journal. - Molecular Pathology and Personalized Medicine:
There is a growing trend toward integrating molecular pathology into personalized medicine frameworks, with research aimed at tailoring treatments based on individual genetic profiles and tumor characteristics.
Declining or Waning
- Traditional Cytogenetics:
There is a noticeable decline in publications focused on traditional cytogenetic methods, such as karyotyping and fluorescence in situ hybridization (FISH), as molecular techniques like NGS become the preferred approach for genomic analysis. - Basic Molecular Biology Techniques:
Basic molecular biology techniques, such as Sanger sequencing and conventional PCR, are being overshadowed by high-throughput and more sensitive methods, leading to fewer publications in these areas. - Single-Condition Focus Studies:
Research that focuses solely on single conditions without exploring broader implications or multi-condition approaches is becoming less common, as the trend shifts toward integrative and multi-faceted studies. - Non-Clinical Applications of Diagnostics:
There is a waning interest in the applications of molecular diagnostics outside clinical settings, such as environmental monitoring or food safety, as the journal increasingly centers on clinical relevance and patient care.
Similar Journals
Annual Review of Cancer Biology
Bridging Academia and Clinical Applications in Cancer ResearchAnnual Review of Cancer Biology is a pivotal journal published by Annual Reviews, specializing in the rapidly evolving field of cancer research. With an impact factor positioned in the distinguished Q1 quartile of Cancer Research, Cell Biology, and Oncology categories, this journal ensures that it showcases the highest quality of scholarly contributions. Indexed in Scopus, it ranks among the top in its fields, reflecting its strong influence and relevance, with remarkable percentiles indicating its esteemed position within the research community. Although not an open-access journal, it provides a comprehensive platform for advancing the frontiers of cancer biology through rigorously curated reviews, highlighting key developments, breakthroughs, and future directions that inform both academia and clinical applications. As a valuable resource for researchers, professionals, and students, the Annual Review of Cancer Biology serves as an essential guide for understanding and addressing the complexities of cancer biology today.
Byulleten Sibirskoy Meditsiny
Empowering Discovery in Biomedicine for a Global AudienceByulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.
Fetal and Pediatric Pathology
Bridging research and clinical practice for young patients.Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Unveiling Cutting-Edge Research in Clinical PathologyThe American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.
International Journal of Clinical and Experimental Pathology
Connecting Researchers and Practitioners in PathologyInternational Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.
Journal of Pathology Clinical Research
Advancing the Frontiers of Pathology and Forensic MedicineThe Journal of Pathology Clinical Research is a prestigious academic platform published by WILEY, dedicated to advancing the field of pathology and forensic medicine. Since its inception in 2015, this Open Access journal has championed the dissemination of cutting-edge research relevant to both clinical practice and laboratory science, allowing for greater visibility and accessibility to researchers, professionals, and students worldwide. With a robust Q1 ranking in the Pathology and Forensic Medicine category for 2023, it stands as a critical resource for those seeking to stay at the forefront of the field, currently positioned at rank #29 out of 208 according to Scopus metrics, placing it in the 86th percentile. The journal's commitment to high-quality peer-reviewed articles fosters an environment of scholarly exchange that is essential for innovation and professional growth in pathology and forensic studies. Researchers and practitioners alike are encouraged to contribute and engage with a community dedicated to excellence in clinical research.
Annual Review of Pathology-Mechanisms of Disease
Decoding Disease: A Comprehensive Review of MechanismsAnnual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.
Cold Spring Harbor Molecular Case Studies
Driving innovation through rigorous research and discovery.Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.
Biomarker Research
Advancing biomarker discovery for a healthier tomorrow.Biomarker Research is a leading open access journal published by BMC, dedicated to advancing the field of biomarker discovery and clinical application. Since its inception in 2013, this journal has become a crucial resource for researchers and professionals in biochemistry, clinical biochemistry, and molecular medicine, achieving a prestigious Q1 ranking in each category in 2023. With an E-ISSN of 2050-7771, it maintains a strong reputation for disseminating high-quality research and innovative findings that contribute to the understanding of disease mechanisms and the development of novel diagnostics and therapeutics. The journal is accessible to a global audience, ensuring that vital research is freely available to promote collaboration and accelerate scientific progress. Operating out of the United Kingdom, Biomarker Research plays a significant role in addressing some of the most pressing challenges in medical research, making it an essential resource for academics, clinicians, and industry professionals alike.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
Connecting global researchers in laboratory medicine.JOURNAL OF CLINICAL LABORATORY ANALYSIS is a premier, peer-reviewed journal published by WILEY, focusing on the expansive field of laboratory medicine. With its ISSN 0887-8013 and E-ISSN 1098-2825, this open access journal has been serving the scientific community since 1987. As of 2023, it holds a notable impact in various domains, achieving category quartiles in Biochemistry, Clinical Biochemistry, Hematology, and more, showcasing its significance across multiple disciplines such as Medical Laboratory Technology and Public Health. Ranked impressively, it is placed 7th in Medical Laboratory Technology, reflecting its crucial role in advancing clinical practice and research. The journal aims to disseminate innovative research findings, methodologies, and reviews that can catalyze advancements in laboratory practices and improve patient outcomes. Accessible to a global audience since its transition to open access in 2019, the journal is not just limited to professionals but is also a valuable resource for students and researchers seeking to stay updated in this dynamic field. For more information, visit the journal's website.